Flasco v. Commissioner of the Social Security Administration

CourtDistrict Court, N.D. Ohio
DecidedMay 5, 2025
Docket5:24-cv-01892
StatusUnknown

This text of Flasco v. Commissioner of the Social Security Administration (Flasco v. Commissioner of the Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Flasco v. Commissioner of the Social Security Administration, (N.D. Ohio 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

COREY FLASCO, ) Case No. 5:24-cv-01892 ) Plaintiff, ) MAGISTRATE JUDGE ) REUBEN J. SHEPERD v. ) ) COMMISSIONER OF SOCIAL SECURITY, ) MEMORANDUM OPINION ADMINISTRATION, ) AND ORDER ) Defendant. )

I. Introduction

Plaintiff, Corey Flasco (“Flasco”), seeks judicial review of the final decision of the Commissioner of Social Security denying his application for disability insurance benefits (“DIB”) under Title II of the Social Security Act and supplemental security income (“SSI”) under Title XVI of the Social Security Act. Flasco raises two issues on review of the Administrative Law Judge’s (“ALJ’s”) decision, arguing: 1. The ALJ erred in finding the opinions of the treating psychiatrist, Dr. Desai not persuasive, by cherry picking evidence of opinions of Dr. Saghafi, and

2. The ALJ erred in the evaluation of Dr. Desai’s opinions regarding supportability and consistency.

This matter is before me pursuant to 42 U.S.C. §§ 405(g), and 1383(c)(3). The parties consented to the jurisdiction of the magistrate judge pursuant to 28 U.S.C. § 636(c)(1). As substantial evidence supports the ALJ’s decision and because Flasco has failed to identify any error of law in the ALJ’s evaluation of his case, I affirm Commissioner’s final decision. II. Procedural History On June 24, 2022, Flasco filed applications for DIB and SSI alleging his disability began September 30, 2018. (Tr. 336-42, 343-49). The claims were denied initially and on reconsideration. (Tr. 200, 201, 220, 229). On April 7, 2023, he had a hearing before an ALJ. (Tr. 241-44). Flasco, with representation, and a vocational expert (“VE”) testified before the ALJ on

October 19, 2023. (Tr. 165-99). On October 31, 2023, the ALJ issued a written decision finding Flasco not disabled. (Tr. 91-115). The Appeals Council denied his request for review on August 26, 2024, thereby rendering the ALJ’s decision the final decision of the Commissioner. (Tr. 1-7). Flasco timely instituted this action on October 30, 2024. (ECF Doc. 1). III. Evidence A. Personal, Educational and Vocational Evidence. Flasco was 49 years old on the alleged onset date. (Tr. 109). He has at least a high school education. (Id.). He has past relevant work as a sales manager, DOT# 163.167-018, sedentary per

DOT, light as actually performed, with an SVP of 8. (Id.).Relevant Medical Evidence Records submitted from the Cleveland Clinic show that Flasco attended an office visit for follow up treatment of hairy cell leukemia. (Tr. 468). He presented with pancytopenia and splenomegaly and was noted to have shotty retroperitoneal lymphadenopathy. (Id.). Progress notes indicate that Flasco had completed one cycle of 2-CdA in March 2017, and a bone marrow biopsy three months later had shown that he had achieved complete remission. (Id.). On October 18, 2020, Flasco presented to the Akron General Medical Center Emergency Department complaining of anxiety and depression he had been experiencing since being laid off from his job. (Tr. 763). He reported being unable to sleep and was requesting medications to help address it. (Id.). He expressed a willingness to begin counseling (id.) but denied suicidal ideations despite telling his mother he should just kill himself. (Tr. 764). On November 1, 2021, Flasco was found in his parked car appearing dazed and “altered.” (Tr. 533). His mother reported that a similar incident had occurred about a week or two prior when his brother had found him wandering in the woods. (Tr. 539). He tested positive for

opiates, and his version of events changed throughout his encounter at the emergency department. (Tr. 533-58). He was assessed with an altered mental state and rhabdomyolysis. (Tr. 550). He was noted to be encephalopathic although an MRI and EEG were both benign. (Tr. 556). In gathering further history from his wife, from whom Flasco has been separated for ten years, medical staff learned that Flasco had been irritable recently, and he had taken a lot of money out of their shared account. (Id.). She also reported another similar incident where their son had found Flasco after he had become lost, and, once found, he appeared confused and had soiled himself. (Id.). Flasco’s mother also told of another recent incident where he had been hospitalized due to suicidal ideations. (Tr. 641).

Flasco was seen for a psychiatric consultation on November 1, 2021, by Rachel Bowden, APRN-CNP, who wrote that that his mentation had improved and he had less impairment in attention, concentration, and working memory. (Tr. 558). Flasco did continue to report poor sleep and anxiety but remained disinterested in receiving psychiatric care. (Id.). He was diagnosed with altered mental status, generalized anxiety disorder, and depression. (Tr. 562). On August 26, 2022, Flasco attended an office visit with Bharat Shah, M.D., who assessed him with severe recurrent major depression without psychotic features and generalized anxiety disorder and formulated a treatment plan. (Tr. 858). Dr. Shah next saw Flasco on September 9, 2022, when Flasco noted that he was feeling better than before, and that his Effexor prescription was helping him with his motivation. (Tr. 860). He still had some feelings of anxiety and depression, but he did not have agitation, aggression, or impulsivity. (Id.). His memory was noted to be “intact.” (Id.). At his next session on September 19, 2022, his mother noted that Flasco seemed more motivated, and his mood had improved. (Tr. 861). By October 3, 2022, Flasco was reporting to Dr. Shah that he was engaging in more

activities, including cutting his grass, walking his dog several times daily, and applying for jobs. (Tr. 862). On October 17, 2022, Flasco reported he was talking to a friend about joining his landscaping business. (Tr. 863). Flasco mentioned at his November 14, 2022 visit that he had seen significant improvement since he first began seeing Dr. Shah, though he still had anxiety at night and when he considered going to job interviews. (Tr. 864). Examination notes from that session describe Flasco as coherent and logical, with his memory intact and no suicidal or homicidal thoughts, plans, or intentions. (Id.). By December 5, 2022, Flasco was reporting less anxiety and depression and felt “more courage in applying for jobs.” (Tr. 865). On January 26, 2023, Flasco went for an initial diagnostic assessment with Sonia Desai,

M.D., at Comprehensive Minds, LLC. (Tr. 887-91). His chief complaint was constant anxiety and depression leading to compulsive activity, including excessive cleaning and dog walking. (Tr. 887). He also reported panic attacks and short-term memory loss. (Id.). His mother attended the assessment with him and reported his mental health had grown worse in the last year and he had been isolating and having paranoid delusions. (Id.). Dr. Desai diagnosed him with obsessive- compulsive disorder (“OCD”) and major depressive disorder, recurrent, moderate. (Tr. 891). In a progress note dated February 23, 2023, Dr. Desai noted that Flasco’s medication efficacy and compliance were excellent; that his immediate recent and past memory were all “good”; and that his condition was generally improving. (Tr. 901-02). Progress notes from March 23, 2023 (Tr. 903), April 6, 2023 (Tr. 905), May 4, 2023 (Tr. 954), May 11, 2023 (Tr. 965), June 1, 2023 (Tr. 977), and June 29, 2023 (Tr. 989), all document similar findings. On July 25, 2023, the progress notes are very similar, but also document increases of his dosages of Klonopin and clomipramine. (Tr. 1021).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cabán Hernández v. Philip Morris USA, Inc.
486 F.3d 1 (First Circuit, 2007)
Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Barbara Combs v. Commissioner of Social Security
459 F.3d 640 (Sixth Circuit, 2006)
David Bowen v. Commissioner of Social Security
478 F.3d 742 (Sixth Circuit, 2007)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Cheryl Minor v. Commissioner of Social Security
513 F. App'x 417 (Sixth Circuit, 2013)
Justice v. Commissioner Social Security Administration
515 F. App'x 583 (Sixth Circuit, 2013)
Blakley v. Commissioner of Social Security
581 F.3d 399 (Sixth Circuit, 2009)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Masters v. Commissioner of Social Security
707 F. App'x 374 (Sixth Circuit, 2017)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Flasco v. Commissioner of the Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/flasco-v-commissioner-of-the-social-security-administration-ohnd-2025.